1.50Open1.15Pre Close158 Volume62 Open Interest30.00Strike Price18.64KTurnover177.15%IV7.96%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry1.10Extrinsic Value100Contract SizeAmericanOptions Type-0.3554Delta0.0754Gamma24.15Leverage Ratio-0.3492Theta-0.0009Rho-8.58Eff Leverage0.0104Vega
Scholar Rock Stock Discussion
Breakthrough: Scholar Rock's SMA Drug Shows 30.4% Patient Improvement in Phase 3 Trial
Scholar Rock's $437M War Chest: Can Their SMA Drug Deliver Returns for Investors?
Can This Phase 3 SMA Drug Transform Muscle Disease Treatment? Key Data Coming at MDA Conference
No comment yet